CURR - Currenc Group Inc. Ordinary Shares

CURR - Currenc Group Inc. Ordinary Shares

None

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Currenc Group Inc. Announces CEO Transition - Currenc Group ( NASDAQ:CURR )

Benzinga • 1 month ago • score: 0.69

SINGAPORE, Aug. 15, 2025 ( GLOBE NEWSWIRE ) -- Currenc Group Inc. CURR ( "Currenc" or the "Company" ) , a fintech pioneer empowering financial institutions worldwide with artificial intelligence ( AI ) solutions, today announced that Dr. Ronnie Hui has stepped down as Chief Executive Officer.

Currenc Group Inc. Announces CEO Transition

GlobeNewswire • 1 month ago • score: 0.70

SINGAPORE, Aug. 15, 2025 ( GLOBE NEWSWIRE ) -- Currenc Group Inc. ( Nasdaq: CURR ) ( "Currenc" or the "Company" ) , a fintech pioneer empowering financial institutions worldwide with artificial intelligence ( AI ) solutions, today announced that Dr. Ronnie Hui has stepped down as Chief Executive ...

Currenc Group's Founder and Executive Chairman Converts $54.6 Million in Loans to Equity

GlobeNewswire • 1 month, 1 week ago • score: 0.51

Strengthening Capital Structure and Signaling Confidence in Growth Strengthening Capital Structure and Signaling Confidence in Growth ...

Currenc Group Inc. Initiates Investigation into Suspected Illegal Short Selling Amid Global Expansion - Currenc Group ( NASDAQ:CURR )

Benzinga • 1 month, 2 weeks ago • score: 0.58

SINGAPORE, July 31, 2025 ( GLOBE NEWSWIRE ) -- Currenc Group Inc.

Currenc Group Inc. Initiates Investigation into Suspected Illegal Short Selling Amid Global Expansion

GlobeNewswire • 1 month, 2 weeks ago • score: 0.60

SINGAPORE, July 31, 2025 ( GLOBE NEWSWIRE ) -- Currenc Group Inc. ( Nasdaq: CURR ) ( "Currenc" or the "Company" ) , a fintech pioneer empowering financial institutions worldwide with artificial intelligence ( AI ) solutions, today announced that it has retained Shareholder Intelligence Services, ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Avenir Wellness Solutions, Inc., through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness. The company is headquartered in Sherman Oaks, California.

52W High

$3.92

52W Low

$0.33

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

Source: Overview

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

2.11

P/S (TTM) (<3 favorable)

3.09

P/B (<3 favorable)

N/A

Ownership

Source: Overview

Insiders (1–5% typical)

0.00%

Institutions (25–75% balanced)

0.00%

Shares Outstanding

35,000,000

Float

0

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Source: Overview

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

N/A

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

-0.0173

Previous

-0.0119

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025